Entity Shareholding

Shareholder: Wacker Chemicals Finance B.V.
Scenario: SS | Default Shareholder Scenario
Percentage: 100.00%
From: 06/2016
To: 12/2050
Consolidation: U
Multiple Shareholders
Document: https://www.wacker.com/cms/media/en/asset/about_wacker/wacker_at_a_glance/annual_report/annual_report_21.pdf
Description: In 2016, our WACKER BIOSOLUTIONS division acquired a large-scale fermentation plant for producing fermentation-based cystine in León, Spain. WACKER is the world’s first company to bioengineer cystine